logo-loader
viewConcepta

Concepta jumps as it inks deal to sell myLotus in Boots' chemists

The healthcare firm said the agreement with Walgreens Boots Alliance would allow it to supply Boots stores in the UK as well as other partners across EU markets

Boots sign
The Boots deal forms a part of Concepta's plan to roll out myLotus across the EU

Concepta PLC (LON:CPT) shares jumped in mid-morning trading Tuesday after it inked an agreement to supply its myLotus fertility testing kit to high street chemist Boots.

The healthcare firm said the agreement with Walgreens Boots Alliance Inc (NASDAQ:WBA),  which owns both Boots and US pharmacy chain Walgreens, would allow it to supply Boots stores in the UK as well as other WBA partners across EU markets that use the CE-Mark, a quality standard for the European Economic Area that myLotus achieved last October.

READ: Concepta hails successful UK launch of myLotus fertility testing product

myLotus is a self-testing kit that allows women to measure their fertility levels and determine when they are most likely to become pregnant naturally, offering an alternative to expensive treatments like in-vitro fertilisation (IVF).

Matthew Walls, chairman of Concepta, said the firm was “delighted to work with such a respected British high-street brand” and was now preparing its roll-out plans for the EU market.

Investor hails deal as “validation” of myLotus appeal

In a separate announcement, Mercia Technologies PLC (LON:MERC), an investment group that owns an 18.2% stake in Concepta, hailed the deal as “validation” that the myLotus product had “significant commercial appeal”.

“This new partnership will play a pivotal role in myLotus being more widely available across the UK and overseas", said Peter Dines, Mercia’s chief operating officer who is also a non-executive director of Concepta.

Shares were up 4% at 3.95p.

--Adds share price--

Quick facts: Concepta

Price: 1.075 GBX

LSE:CPT
Market: LSE
Market Cap: £2.85 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Helix Technologies following up strong 2019 with success in 2020

Helix Technologies (OTCQB: HLIX) President of Data Services Garvis Toler joined Steve Darling from Proactive Vancouver to discuss the company releasing their 2019 financial numbers which were very strong and also what milestones they hit to close the year.  Toler also told Proactive...

4 hours, 19 minutes ago

2 min read